EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

Essential Tremor and Digital Biomarkers: A Scoping Review Using the TRACE Framework to Map Readiness for Clinical Trials and Routine Practice

David Ledingham iD, Antonella Macerollo iD, Nicola Pavese iD

Tremor and Other Hyperkinetic Movements · 08.06.2026 · 16 · 39

DOI: 10.5334/tohm.1205 ↗

Kurz gefasst

Scoping Review in der Zeitschrift Tremor and Other Hyperkinetic Movements, online erschienen am 08.06.2026. Verfasst von David Ledingham und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Ageing Research Unit, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Essential Tremor, Clinical Trials as Topic, Wearable Electronic Devices. Die Arbeit nennt 184 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Essential Tremor (ET) is the most prevalent movement disorder in adults yet remains underrepresented in digital biomarker research. As therapies evolve, the absence of validated digital endpoints represents a growing translational gap. We introduce TRACE (Technology Readiness And Clinical Evidence), a novel five-tier validation maturity framework, and apply it in a scoping review of the ET digital biomarker literature.

Methods

A PRISMA-ScR scoping review was conducted across four databases (2000–2025). Studies were eligible if they reported quantitative digital tremor measurement in ten or more ET participants. Each study was assigned to the highest satisfied TRACE tier: technical verification (T1), referenced clinical validity (T2), ambulatory and longitudinal utility (T3), clinical trial readiness (T4), or economic and implementation readiness (T5).

Results

One hundred and sixty-five studies were included: wearable inertial measurement units (n = 114), digitised handwriting (n = 16), computer vision (n = 15), surface EMG (n = 10), voice (n = 6), and gait (n = 4). One hundred and fifty-four (93%) were T2; nine T3; two T4, both deploying the Cala Health TAPS wristband; none T5. Home or ambulatory deployment was present in 13 studies, minimum detectable change data in three, and patient-reported outcome correlation in 11.

Discussion

Only 11 studies across two modalities were classified beyond T2, demonstrating ambulatory or longitudinal evidence beyond supervised clinical validation; the TAPS wristband is the sole platform to achieve Tier 4. Home deployment, minimum detectable change derivation anchored to patient experience, and patient-reported outcome integration remain key prerequisites before digital tremor metrics can function as trial endpoints or inform routine practice. Highlights: Despite rapid advances in digital outcome measures for Parkinson’s disease, essential tremor remains largely overlooked. Reviewing 165 studies across six sensing modalities, we introduce TRACE, a five-tier validation framework, and find that while 93% of devices demonstrate basic clinical validity, only two achieve clinical trial readiness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Essential TremorClinical Trials as TopicWearable Electronic DevicesHumansBiomarkersDigital Health

Stichwörter der Autor:innen

Clinical trialsDigital biomarkersEssential tremorScoping ReviewTRACE frameworkWearable sensors

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Clinical Ageing Research Unit, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, UK.
  • Neurosciences, Newcastle Upon Tyne NHS Foundation Trust, Newcastle Upon Tyne, UK.
  • Translational and Clinical Research Institute, The Medical School, Newcastle University, Newcastle Upon Tyne, UK.
  • NIHR Newcastle Biomedical Research Centre (BRC), Newcastle upon Tyne, UK.
  • The Walton Centre NHS Foundation Trust for Neurology and Neurosurgery, Liverpool, UK.
  • Institute of Systems, Molecular and Integrative Biology, The University of Liverpool, UK.

ORCID-Profile: David Ledingham, Antonella Macerollo, Nicola Pavese

Zitieren

APA

Ledingham, D., Macerollo, A., & Pavese, N. (2026). Essential Tremor and Digital Biomarkers: A Scoping Review Using the TRACE Framework to Map Readiness for Clinical Trials and Routine Practice. Tremor and Other Hyperkinetic Movements, 16, 39. https://doi.org/10.5334/tohm.1205

Vancouver

Ledingham D, Macerollo A, Pavese N. Essential Tremor and Digital Biomarkers: A Scoping Review Using the TRACE Framework to Map Readiness for Clinical Trials and Routine Practice. Tremor and Other Hyperkinetic Movements. 2026;16:39. doi:10.5334/tohm.1205

BibTeX
@article{Ledingham2026,
  author = {Ledingham, David and Macerollo, Antonella and Pavese, Nicola},
  title = {Essential Tremor and Digital Biomarkers: A Scoping Review Using the TRACE Framework to Map Readiness for Clinical Trials and Routine Practice},
  journal = {Tremor and Other Hyperkinetic Movements},
  year = {2026},
  volume = {16},
  pages = {39},
  doi = {10.5334/tohm.1205}
}
Kostenlos starten →